Cannara Biotech Inc.
LOVE.TO
TSX
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Net Income | 1.22M | 744.60K | 2.42M | 2.95M | 2.32M |
| Total Depreciation and Amortization | 960.20K | 1.13M | 1.63M | 899.50K | 1.14M |
| Total Amortization of Deferred Charges | 86.00K | 34.40K | 36.90K | -- | -- |
| Total Other Non-Cash Items | 1.88M | 3.91M | 1.01M | 1.40M | 1.06M |
| Change in Net Operating Assets | -1.98M | -117.00K | -3.03M | 4.65M | -6.30M |
| Cash from Operations | 2.16M | 5.70M | 2.06M | 9.89M | -1.78M |
| Capital Expenditure | -2.37M | -3.31M | -1.07M | -1.57M | -1.03M |
| Sale of Property, Plant, and Equipment | 102.70K | -- | 102.10K | 11.30K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 64.70K | 42.70K | 60.30K | 38.70K | 50.30K |
| Cash from Investing | -2.20M | -3.27M | -906.30K | -1.52M | -976.00K |
| Total Debt Issued | -- | -- | 0.00 | -- | -- |
| Total Debt Repaid | -658.60K | -654.40K | -655.10K | -1.67M | -162.30K |
| Issuance of Common Stock | 6.30M | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -197.90K | -590.80K | -976.40K | -747.80K | -1.10M |
| Cash from Financing | 3.99M | -892.00K | -1.19M | -1.72M | -879.80K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.95M | 1.55M | -34.70K | 6.65M | -3.64M |